Evidence map›Paper›PMID 25368328›Full record

ArticleThe Journal of biological chemistry2014

A conserved three-nucleotide core motif defines Musashi RNA binding specificity.

N Ruth Zearfoss, Laura M Deveau, Carina C Clingman, Eric Schmidt, Emily S Johnson, Francesca Massi, Sean P Ryder

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

N Ruth ZearfossFrom the Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Laura M DeveauFrom the Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Carina C ClingmanFrom the Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Eric SchmidtFrom the Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Emily S JohnsonFrom the Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Francesca MassiFrom the Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Sean P RyderFrom the Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605 Sean.Ryder@umassmed.edu.
University of Massachusetts Chan Medical School · US

Funding

Medical Scientist Training at UMMS Administrative SupplementT32GM107000 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KIEFE, CATARINA I. · 2013 to 2022
$4.9M
RNA recognition by maternal gene silencers in nematodesR01GM081422 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RYDER, SEAN PATRICK · 2008 to 2012
$1.7M
Structure, dynamics and function of RNA binding proteinsR01GM098763 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MASSI, FRANCESCA · 2011 to 2015
$1.6M
Comparative HTS to identify small molecule effectors of cell fate specificationR01GM098643 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RYDER, SEAN PATRICK · 2012 to 2014
$917k
NIGMS NIH HHS GM081422NIGMS NIH HHS GM098643NIGMS NIH HHS GM098763NIGMS NIH HHS R01 GM081422NIGMS NIH HHS R01 GM098643NIGMS NIH HHS R01 GM098763NIGMS NIH HHS T32 GM107000
6 · The paper itself

Abstract

Musashi (MSI) family proteins control cell proliferation and differentiation in many biological systems. They are overexpressed in tumors of several origins, and their expression level correlates with poor prognosis. MSI proteins control gene expression by binding RNA and regulating its translation. They contain two RNA recognition motif (RRM) domains, which recognize a defined sequence element. The relative contribution of each nucleotide to the binding affinity and specificity is unknown. We analyzed the binding specificity of three MSI family RRM domains using a quantitative fluorescence anisotropy assay. We found that the core element driving recognition is the sequence UAG. Nucleotides outside of this motif have a limited contribution to binding free energy. For mouse MSI1, recognition is determined by the first of the two RRM domains. The second RRM adds affinity but does not contribute to binding specificity. In contrast, the recognition element for Drosophila MSI is more extensive than the mouse homolog, suggesting functional divergence. The short nature of the binding determinant suggests that protein-RNA affinity alone is insufficient to drive target selection by MSI family proteins.

Indexed as

AlgorithmsAnimalsBase SequenceBinding SitesConserved SequenceDrosophila ProteinsFluorescence PolarizationHumansKineticsMagnetic Resonance SpectroscopyMiceMolecular Sequence DataMutationNerve Tissue ProteinsNucleotide MotifsProtein BindingDrosophila ProteinsMsi1h protein, mouseMsi2h protein, mouseMSI2 protein, humanmsi protein, DrosophilaNerve Tissue ProteinsRNARNA-Binding ProteinsBinding SpecificityCell ProliferationFluorescence AnisotropyRNARNA-binding ProteinRNA-Protein InteractionRNA RecognitionRRM

Identifiers

PMID25368328
PMCPMC4271237
OpenAlexW1974242799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.